Showing results (891-900 of 1,080) with videos related to

Sort By:
Pageof 108
The Oncologist|May 11, 2017
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective StudyTalia Golan, Maria Raitses-Gurevich, Robin K Kelley, et al.
Future Oncology (London, England)|February 21, 2018
Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinomaThomas T DeLeon, Daniel H Ahn, James M Bogenberger, et al.
Journal of Korean Medical Science|November 12, 1998
Severe aplastic anemia induced by ticlopidine: report of two casesH Bahng, J H Lee, C Suh, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 21, 2016
Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal womenH Kim, K H Baek, S-Y Lee, et al.
Cephalalgia : an International Journal of Headache|May 18, 2021
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approachOrit Cohen-Barak, Andrijana Radivojevic, Aksana Jones, et al.
Molecular and Cellular Biology|September 13, 2006
Requirement of hCenexin for proper mitotic functions of polo-like kinase 1 at the centrosomesNak-Kyun Soung, Young Hwi Kang, Keetae Kim, et al.
Head & Neck|May 5, 2016
Endoscopy versus imaging: Analysis of surveillance methods in sinonasal malignancySammy Khalili, Douglas M Worrall, Steve Brooks, et al.
Journal of Viral Hepatitis|June 1, 2018
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatmentK Agarwal, S H Ahn, M Elkhashab, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2018
A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival resultsX Pivot, I Bondarenko, Z Nowecki, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2001
Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2':6',2"-, 2,2':6',3"- and 2,2':6',4"-terpyridine derivativesL X Zhao, T S Kim, S H Ahn, et al.
Pageof 108